Literature DB >> 22168920

Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study.

T B Eilertsen1, E Vanky, S M Carlsen.   

Abstract

OBJECTIVE: To test the hypothesis that endocrine and metabolic factors predispose to preterm birth.
DESIGN: A cross-sectional, case-control study.
SETTING: Namsos Hospital district (Namsos, Norway). POPULATION: Women from the Namsos Hospital district with previous preterm births (n = 114) were compared with matched controls with term births (n = 127).
METHODS: A clinical examination including transvaginal ultrasound was performed. Fasting blood samples were collected and an oral glucose tolerance test was performed. MAIN OUTCOME MEASURES: The prevalence of polycystic ovary syndrome (PCOS) diagnosis (Rotterdam criteria) and serum levels of androgens, glucose and insulin.
RESULTS: Twenty-nine of 114 women (25.4%) met the PCOS criteria among women with preterm birth, compared with 18 of 127 (14.2%) among controls (P = 0.03). Eight (7.1%) women with preterm birth were diagnosed with diabetes compared with none in the control group (P < 0.01). Hirsutism was present in 34 (29.8%) women with preterm birth versus 12 (9.4%) in the control group (P < 0.01).
CONCLUSIONS: The prevalences of PCOS, diabetes and hirsutism are increased among women with a history of preterm birth. This indicates that endocrine and/or metabolic factors may be involved in the pathogenesis of preterm birth. Women experiencing preterm delivery may have an increased risk of developing diabetes and PCOS later in life.
© 2011 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2011 RCOG.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22168920     DOI: 10.1111/j.1471-0528.2011.03206.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

Review 1.  The incidence of gestational diabetes mellitus among women with polycystic ovary syndrome: a meta-analysis of longitudinal studies.

Authors:  Qingzi Yan; Dan Qiu; Xiang Liu; Qichang Xing; Renzhu Liu; Yixiang Hu
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-29       Impact factor: 3.105

2.  Metformin serum concentrations during pregnancy and post partum - A clinical study in patients with polycystic ovary syndrome.

Authors:  Ketil Arne Espnes; Arne Hønnås; Tone S Løvvik; Per Ole M Gundersen; Audhild Naavik; Eirik Skogvoll; Andreas A Westin; Olav Spigset; Eszter Vanky
Journal:  Basic Clin Pharmacol Toxicol       Date:  2022-01-18       Impact factor: 3.688

3.  HbA1c as screening for gestational diabetes mellitus in women with polycystic ovary syndrome.

Authors:  Ingrid Hov Odsæter; Arne Åsberg; Eszter Vanky; Sven Magnus Carlsen
Journal:  BMC Endocr Disord       Date:  2015-08-06       Impact factor: 2.763

4.  Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome.

Authors:  Qing Xiao; Yong-Yi Cui; Jine Lu; Guo-Zheng Zhang; Fang-Ling Zeng
Journal:  Int J Endocrinol       Date:  2016-03-14       Impact factor: 3.257

5.  Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?

Authors:  Sverre C Christiansen; Tina B Eilertsen; Eszter Vanky; Sven M Carlsen
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.